Conventional partial pancreatoduodenectomy versus an uncinate first, extended partial pancreatoduodenectomy approach for the resection of pancreatic head cancer: the randomized, controlled PancER trial

Author:

Heger Patrick12,Diener Markus K.12,Feißt Manuel3,Gaida Matthias M.4,Klose Christina3,Knebel Phillip1,Klotz Rosa15,Dörr-Harim Colette1,Mihaljevic André L.16

Affiliation:

1. Department of General, Visceral and Transplantation Surgery , University Hospital Heidelberg , Heidelberg , Germany

2. Department of General , Visceral and Thoracic Surgery , Nürnberg , Germany

3. Institute of Medical Biometry (IMBI) , University of Heidelberg , Heidelberg , Germany

4. Institute of Pathology , University of Mainz , Mainz , Germany

5. The Study Center of the German Society of Surgery (SDGC) , University Hospital Heidelberg , Heidelberg , Germany

6. Department of General, Visceral and Transplantation Surgery , 27203 University Hospital Tübingen , Tübingen , Germany

Abstract

Abstract Objectives After pancreatoduodenectomy (PD) due to pancreatic cancer, recurrence is frequent in almost half of the patients. The rate of R0 resections is associated with the probability of local recurrence and overall survival. A potential intervention to improve the rate of R0 resections is a more radical resection along the superior mesenteric artery (SMA); however, randomized data of such an approach are lacking. Therefore, we conducted the randomized, controlled PancER trial to evaluate the effect of an extended PD compared with conventional PD. Methods Patients were randomized to either an extended PD consisting of a modified Kocher maneuver with partial resection of the prerenal fascia, an uncinate process first approach with systematic mesopancreatic dissection along the SMA equivalent to level III dissection according to Inoue, or conventional PD. The primary endpoint, rate of R0 resections, and other perioperative outcomes were compared. Results A total of 50 patients were randomly assigned to extended PD (n=24) or conventional PD (n=26). R0 resections were 10 % more frequent in the extended PD group than in the conventional group (75.0 vs. 64.7 %), which was not statistically significant (p=0.59). Patients self-reported more diarrhea symptoms following extended PD after 30 days (p<0.01). Other perioperative outcomes as well as long-term outcomes were comparable between the two groups. Conclusion The PancER trial shows that extended PD with more radical resection along the SMA can be performed with comparable perioperative outcomes to conventional PD. Although the intervention improved the R0 resection rate by 10 %, this increase was below expectation. Therefore, an even more radical PD resection technique involving not only the SMA but also the celiac and hepatic artery (TRIANGLE operation) was developed at Heidelberg University. The TRIANGLE operation is currently being evaluated in a randomized controlled multicenter trial. The results of the PancER trial served as pilot data for this subsequent study.

Publisher

Walter de Gruyter GmbH

Reference35 articles.

1. Robert-Koch Institut. Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. Krebs in Deutschland für 2017/2018; 2021. Available from: https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2021/krebs_in_deutschland_2021.pdf?__blob=publicationFile.

2. American Cancer Society. Cancer facts & figures. Atlanta. 2015 09.05.2019. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2015/cancer-facts-and-figures-2015.pdf.

3. Hartwig, W, Werner, J, Jager, D, Debus, J, Buchler, MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol 2013;14:e476–85. https://doi.org/10.1016/s1470-2045(13)70172-4.

4. Tanaka, M, Mihaljevic, AL, Probst, P, Heckler, M, Klaiber, U, Heger, U, et al.. Initial recurrence pattern after resection for pancreatic cancer: a systematic review and meta-analysis. submitted; 2019.

5. Neoptolemos, JP, Palmer, DH, Ghaneh, P, Psarelli, EE, Valle, JW, Halloran, CM, et al.. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 2017;389:1011–24. https://doi.org/10.1016/s0140-6736(16)32409-6.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3